(State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |
Securities registered pursuant to Section 12(b) of the Act: | ||||||||||||||
Title of each class | Trading Symbol | Name of each exchange on which registered | ||||||||||||
For | Against | Abstain | Non-Votes | |||||||||||
Sangeeta Bhatia | 218,894,349 | 764,147 | 99,830 | 11,015,309 | ||||||||||
Lloyd Carney | 171,495,897 | 48,046,438 | 215,991 | 11,015,309 | ||||||||||
Alan Garber | 215,786,425 | 3,866,263 | 105,638 | 11,015,309 | ||||||||||
Terrence Kearney | 212,942,050 | 6,706,475 | 109,801 | 11,015,309 | ||||||||||
Reshma Kewalramani | 218,966,434 | 688,982 | 102,910 | 11,015,309 | ||||||||||
Yuchun Lee | 215,699,823 | 3,940,932 | 117,571 | 11,015,309 | ||||||||||
Jeffrey Leiden | 214,407,303 | 5,253,945 | 97,078 | 11,015,309 | ||||||||||
Margaret McGlynn | 218,573,140 | 1,080,345 | 104,841 | 11,015,309 | ||||||||||
Diana McKenzie | 219,445,405 | 208,565 | 104,356 | 11,015,309 | ||||||||||
Bruce Sachs | 208,964,326 | 10,679,348 | 114,652 | 11,015,309 |
For | Against | Abstain | Non-Votes | |||||||||||
202,126,361 | 28,512,419 | 134,855 | 0 |
For | Against | Abstain | Non-Votes | |||||||||||
200,764,722 | 18,817,126 | 176,478 | 11,015,309 |
VERTEX PHARMACEUTICALS INCORPORATED | |||||
(Registrant) | |||||
Date: May 19, 2021 | /s/ Joy Liu | ||||
Joy Liu | |||||
Senior Vice President, General Counsel |
Document and Entity Information Document |
May 19, 2021 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Document Period End Date | May 19, 2021 |
Entity Registrant Name | VERTEX PHARMACEUTICALS INC / MA |
Entity Central Index Key | 0000875320 |
Amendment Flag | false |
Entity Incorporation, State or Country Code | MA |
Entity File Number | 000-19319 |
Entity Tax Identification Number | 04-3039129 |
Entity Address, Address Line One | 50 Northern Avenue |
Entity Address, City or Town | Boston |
Entity Address, State or Province | MA |
Entity Address, Postal Zip Code | 02210 |
City Area Code | 617 |
Local Phone Number | 341-6100 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock, $0.01 Par Value Per Share |
Trading Symbol | VRTX |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |
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end